RU2017129085A - New N-carbamoylmethyl-4-phenyl-2-pyrrolidone formulation - Google Patents

New N-carbamoylmethyl-4-phenyl-2-pyrrolidone formulation Download PDF

Info

Publication number
RU2017129085A
RU2017129085A RU2017129085A RU2017129085A RU2017129085A RU 2017129085 A RU2017129085 A RU 2017129085A RU 2017129085 A RU2017129085 A RU 2017129085A RU 2017129085 A RU2017129085 A RU 2017129085A RU 2017129085 A RU2017129085 A RU 2017129085A
Authority
RU
Russia
Prior art keywords
carbamoylmethyl
phenyl
new
composition
amount
Prior art date
Application number
RU2017129085A
Other languages
Russian (ru)
Other versions
RU2696277C2 (en
RU2017129085A3 (en
Inventor
Кирилл Константинович Сыров
Владимир Викторович Нестерук
Original Assignee
Общество С Ограниченной Ответственностью "Валента - Интеллект"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Общество С Ограниченной Ответственностью "Валента - Интеллект" filed Critical Общество С Ограниченной Ответственностью "Валента - Интеллект"
Priority to RU2017129085A priority Critical patent/RU2696277C2/en
Publication of RU2017129085A3 publication Critical patent/RU2017129085A3/ru
Publication of RU2017129085A publication Critical patent/RU2017129085A/en
Application granted granted Critical
Publication of RU2696277C2 publication Critical patent/RU2696277C2/en

Links

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)

Claims (5)

1. Состав, обладающий ноотропной активностью, включающий фонтурацетам (N-карбамоилметил-4-фенил-2-пирролидон) и 4-фенилпирролидон-2 в количестве не более 1,00 % мас.1. A composition having nootropic activity, including phenylpiracetam (N-carbamoylmethyl-4-phenyl-2-pyrrolidone) and 4-phenylpyrrolidone-2 in an amount of not more than 1.00% wt. 2. Состав по п. 1, отличающийся тем, что упомянутый состав содержит 4-фенилпирролидон-2 в количестве от 0,30 до 0,60% мас.2. The composition according to p. 1, characterized in that the said composition contains 4-phenylpyrrolidone-2 in an amount of from 0.30 to 0.60% wt. 3. Состав по п. 2, отличающийся тем, что упомянутый состав содержит 4-фенилпирролидон-2 в количестве от 0,50 до 0,60% мас.3. The composition according to p. 2, characterized in that the said composition contains 4-phenylpyrrolidone-2 in an amount of from 0.50 to 0.60% wt. 4. Фармацевтическая композиция, обладающая ноотропной активностью, отличающаяся тем, что упомянутая композиция содержит в терапевтически эффективном количестве состав по любому из пп. 1-3 и по меньшей мере один фармацевтически приемлемый носитель.4. A pharmaceutical composition having nootropic activity, characterized in that said composition contains in a therapeutically effective amount a composition according to any one of claims. 1-3 and at least one pharmaceutically acceptable carrier. 5. Лекарственное средство, обладающее ноотропной активностью, в виде таблеток, капсул или инъекций, помещенных в фармацевтически приемлемую упаковку, отличающееся тем, что упомянутое средство содержит фармацевтическую композицию по п. 4.5. A drug having nootropic activity, in the form of tablets, capsules or injections, placed in a pharmaceutically acceptable package, characterized in that the said drug contains a pharmaceutical composition according to claim 4.
RU2017129085A 2017-08-15 2017-08-15 N-carbamoylmethyl-4-phenyl-2-pyrrolidone new composition RU2696277C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2017129085A RU2696277C2 (en) 2017-08-15 2017-08-15 N-carbamoylmethyl-4-phenyl-2-pyrrolidone new composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2017129085A RU2696277C2 (en) 2017-08-15 2017-08-15 N-carbamoylmethyl-4-phenyl-2-pyrrolidone new composition

Publications (3)

Publication Number Publication Date
RU2017129085A3 RU2017129085A3 (en) 2019-02-15
RU2017129085A true RU2017129085A (en) 2019-02-15
RU2696277C2 RU2696277C2 (en) 2019-08-01

Family

ID=65442338

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2017129085A RU2696277C2 (en) 2017-08-15 2017-08-15 N-carbamoylmethyl-4-phenyl-2-pyrrolidone new composition

Country Status (1)

Country Link
RU (1) RU2696277C2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2732245C1 (en) * 2019-08-30 2020-09-14 Ооо "Валента-Интеллект" Novel compositions of n-carbamoylmethyl-4-phenyl-2-pyrrolidone for treating and preventing obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2327458C1 (en) * 2007-02-19 2008-06-27 Открытое акционерное общество "Щелковский витаминный завод" New preparative substance form characterised by nootropic and neuromodulating activity, and related method of production
RU2480214C1 (en) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Formulation possessing modulatory activity with adequate effect, pharmaceutical substance (versions), use of pharmaceutical substance, pharmaceutical and parapharmaceutical composition (versions), method for preparing pharmaceutical formulations

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2732245C1 (en) * 2019-08-30 2020-09-14 Ооо "Валента-Интеллект" Novel compositions of n-carbamoylmethyl-4-phenyl-2-pyrrolidone for treating and preventing obesity

Also Published As

Publication number Publication date
RU2696277C2 (en) 2019-08-01
RU2017129085A3 (en) 2019-02-15

Similar Documents

Publication Publication Date Title
HRP20211543T1 (en) Quinazoline derivatives used to treat hiv
WO2016064082A3 (en) Novel aminoalkyl benzothiazepine derivative and use thereof
MX2017012878A (en) Multicomponent gummy compositions with hard core.
EA201792345A1 (en) PROTECTED FROM APPLICATION NOT FOR THE PURPOSE OF THE MEDICINE FORM WITH IMMEDIATE DELIVERY AND RESISTANCE TO EXTRACTION BY SOLVENTS
EA201792592A1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING TENOFOVIR AND EMTRICITABIN
RU2017116740A (en) COMBINATIONS FOR THE TREATMENT OF MULTIPLE SCLEROSIS
CA3010568A1 (en) Oromucosal nanofiber carriers for therapeutic treatment
MX2018000084A (en) Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin.
JOP20210230A1 (en) Pharmaceutical formulations
RU2017129085A (en) New N-carbamoylmethyl-4-phenyl-2-pyrrolidone formulation
MX2017005163A (en) Onapristone extended-release compositions and methods.
MX2022006940A (en) Pharmaceutical compositions comprising cabotegravir.
EA201991265A1 (en) MEDICINAL FORMS WITH DELAYED DELIVERY CONTAINING DIMETHYLFUMARATE
MX2019001771A (en) Solid pharmaceutical composition comprising amorphous sofosbuvir.
WO2020127819A3 (en) Pharmaceutical composition comprising apixaban
RU2017125150A (en) PHARMACEUTICAL COMPOSITION FOR TREATING OR CREATING TERMS OF REMISSION IN AN ELDERLY PATIENT WITH CANCER OR IN A PATIENT AT THE TERMINAL STAGE OF CANCER
HRP20230693T1 (en) Use of an acetylcholinesterase inhibitor and idalopirdine for reducing falls in parkinson's disease patients
RU2012136190A (en) PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF ARTHROZOARTHRITIS CONTAINING REBAMIPID AS AN ACTIVE INGREDIENT
WO2015166418A3 (en) Pharmaceutical composition for the treatment of allopathic pain, using ketorolac tromethamine and tramadol hydrochloride as an active ingredient
JP2015516451A5 (en)
RU2016131412A (en) APPLICATION OF PARICALCYTOL FOR TREATMENT OF INFLAMMATORY ANEMIA
MX2017012633A (en) Process for manufacturing dry powder blends.
WO2020175922A3 (en) Pharmaceutical composition of single dosage form for treating or preventing hypertension and hyperlipidemia
PH12020550597A1 (en) Formulation having improved hygroscopic property and dissolution rate comprising telmisartan or its pharmaceutically acceptable salt
RU2012137061A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING S-AMLODIPINE NICOTINATE AND THEIR APPLICATION IN THE TREATMENT OF CEREBROVASCULAR DISORDERS

Legal Events

Date Code Title Description
QB4A Licence on use of patent

Free format text: LICENCE FORMERLY AGREED ON 20191203

Effective date: 20191203

QZ41 Official registration of changes to a registered agreement (patent)

Free format text: LICENCE FORMERLY AGREED ON 20191203

Effective date: 20200424